Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 3/2015

01-09-2015 | Original Research

Extra-Hepatic Bile Duct Resection: an Insight in the Management of Gallbladder Cancer

Authors: Durgatosh Pandey, Pankaj Kumar Garg, N. M. L. Manjunath, Jyoti Sharma

Published in: Journal of Gastrointestinal Cancer | Issue 3/2015

Login to get access

Abstract

Background

Involvement of extrahepatic bile duct in gallbladder cancer (GBC) is considered a sign of advanced disease; resection of extrahepatic bile duct in GBC has been a contentious issue considering the poor prognosis of the disease.

Methods

This retrospective study was done in two tertiary teaching hospitals of North India. The case records of all the GBC patients who underwent radical cholecystectomy with extra-hepatic bile duct resection were reviewed. Details concerning the clinical presentation, preoperative therapy, operative procedure, indication of bile duct resection, postoperative complications and outcome were retrieved from the case records. Kaplan–Meier analysis was done to estimate median disease-free survival and overall survival.

Results

There were 17 GBC patients who underwent radical cholecystectomy with resection of extrahepatic bile duct. Median age of the patients was 51 years (range 35–62); male to female ratio was 5:12. Six patients were diagnosed after histopathological examination of resected gallbladder specimen following cholecystectomy (incidental gallbladder cancer). All the patients had R‘0’ resection. The indication for extra-hepatic bile duct resection was direct infiltration of hepatoduodenal ligament in nine, positive cystic duct margin in two, densely adherent pericholedochal lymphnodes in one and associated ampullary growth in one patient. Kaplan–Meier analysis predicted median disease-free survival of 20 months and median overall survival of 26 months.

Conclusion

Extrahepatic bile duct resection to achieve R‘0’ resection in the management of advanced gallbladder cancer is safe with acceptable postoperative morbidity and has potential to improve survival.
Literature
1.
go back to reference Nandakumar A, Gupta PC, Gangadharan P, et al. Geographical pathology revisited: development of an atlas of cancer in India. Int J Cancer. 2005;116:740–54.PubMedCrossRef Nandakumar A, Gupta PC, Gangadharan P, et al. Geographical pathology revisited: development of an atlas of cancer in India. Int J Cancer. 2005;116:740–54.PubMedCrossRef
2.
go back to reference Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118:1591–602.PubMedCrossRef Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118:1591–602.PubMedCrossRef
3.
go back to reference Garg PK, Pandey D, Sharma J. The surgical management of gallbladder cancer. Expert Rev Gastroenterol Hepatol. 2015;9:155–66.PubMedCrossRef Garg PK, Pandey D, Sharma J. The surgical management of gallbladder cancer. Expert Rev Gastroenterol Hepatol. 2015;9:155–66.PubMedCrossRef
4.
go back to reference Reddy SK, Clary BM. Surgical management of gallbladder cancer. Surg Oncol Clin N Am. 2009;18:307–24.PubMedCrossRef Reddy SK, Clary BM. Surgical management of gallbladder cancer. Surg Oncol Clin N Am. 2009;18:307–24.PubMedCrossRef
5.
go back to reference Garg PK, Khurana N, Hadke NS. Subcutaneous and breast metastasis from asymptomatic gallbladder carcinoma. Hepatobiliary Pancreat Dis Int. 2009;8:209–11.PubMed Garg PK, Khurana N, Hadke NS. Subcutaneous and breast metastasis from asymptomatic gallbladder carcinoma. Hepatobiliary Pancreat Dis Int. 2009;8:209–11.PubMed
6.
go back to reference Dixon E, Vollmer CM, Sahajpal A, et al. An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American center. Ann Surg. 2005;241:385–94.PubMedCentralPubMedCrossRef Dixon E, Vollmer CM, Sahajpal A, et al. An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American center. Ann Surg. 2005;241:385–94.PubMedCentralPubMedCrossRef
8.
go back to reference D’Angelica M, Dalal KM, DeMatteo RP, et al. Analysis of the extent of resection for adenocarcinoma of the gallbladder. Ann Surg Oncol. 2009;16:806–16.PubMedCrossRef D’Angelica M, Dalal KM, DeMatteo RP, et al. Analysis of the extent of resection for adenocarcinoma of the gallbladder. Ann Surg Oncol. 2009;16:806–16.PubMedCrossRef
9.
go back to reference Butte JM, Matsuo K, Gonen M, et al. Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries. J Am Coll Surg. 2011;212:50–61.PubMedCrossRef Butte JM, Matsuo K, Gonen M, et al. Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries. J Am Coll Surg. 2011;212:50–61.PubMedCrossRef
10.
go back to reference Eil R, Hansen PD, Cassera M, et al. Bile duct involvement portends poor prognosis in resected gallbladder carcinoma. Gastrointest Cancer Res. 2013;6:101–5.PubMedCentralPubMed Eil R, Hansen PD, Cassera M, et al. Bile duct involvement portends poor prognosis in resected gallbladder carcinoma. Gastrointest Cancer Res. 2013;6:101–5.PubMedCentralPubMed
11.
go back to reference Nishio H, Ebata T, Yokoyama Y, et al. Gallbladder cancer involving the extrahepatic bile duct is worthy of resection. Ann Surg. 2011;253:953–60.PubMedCrossRef Nishio H, Ebata T, Yokoyama Y, et al. Gallbladder cancer involving the extrahepatic bile duct is worthy of resection. Ann Surg. 2011;253:953–60.PubMedCrossRef
12.
go back to reference Agarwal AK, Mandal S, Singh S, et al. Biliary obstruction in gall bladder cancer is not sine qua non of inoperability. Ann Surg Oncol. 2007;14:2831–7.PubMedCrossRef Agarwal AK, Mandal S, Singh S, et al. Biliary obstruction in gall bladder cancer is not sine qua non of inoperability. Ann Surg Oncol. 2007;14:2831–7.PubMedCrossRef
13.
go back to reference Pandey D. Technical description of a regional lymphadenectomy in radical surgery for gallbladder cancer. HPB (Oxford). 2012;14:216–9.CrossRef Pandey D. Technical description of a regional lymphadenectomy in radical surgery for gallbladder cancer. HPB (Oxford). 2012;14:216–9.CrossRef
14.
go back to reference Pandey D. Jaundice after radical cholecystectomy and bile duct resection: a case of postoperative acute viral hepatitis A confounding the clinical picture. Indian J Surg Oncol. 2011;2:210–1.PubMedCentralPubMedCrossRef Pandey D. Jaundice after radical cholecystectomy and bile duct resection: a case of postoperative acute viral hepatitis A confounding the clinical picture. Indian J Surg Oncol. 2011;2:210–1.PubMedCentralPubMedCrossRef
15.
go back to reference Sakamoto Y, Kosuge T, Shimada K, et al. Clinical significance of extrahepatic bile duct resection for advanced gallbladder cancer. J Surg Oncol. 2006;94:298–306.PubMedCrossRef Sakamoto Y, Kosuge T, Shimada K, et al. Clinical significance of extrahepatic bile duct resection for advanced gallbladder cancer. J Surg Oncol. 2006;94:298–306.PubMedCrossRef
16.
go back to reference Shimizu Y, Ohtsuka M, Ito H, et al. Should the extrahepatic bile duct be resected for locally advanced gallbladder cancer? Surgery. 2004;136:1012–7.PubMedCrossRef Shimizu Y, Ohtsuka M, Ito H, et al. Should the extrahepatic bile duct be resected for locally advanced gallbladder cancer? Surgery. 2004;136:1012–7.PubMedCrossRef
17.
go back to reference Nakamura S, Sakaguchi S, Suzuki S, Muro H. Aggressive surgery for carcinoma of the gallbladder. Surgery. 1989;106:467–73.PubMed Nakamura S, Sakaguchi S, Suzuki S, Muro H. Aggressive surgery for carcinoma of the gallbladder. Surgery. 1989;106:467–73.PubMed
18.
go back to reference Matsumoto Y, Fujii H, Aoyama H, et al. Surgical treatment of primary carcinoma of the gallbladder based on the histologic analysis of 48 surgical specimens. Am J Surg. 1992;163:239–45.PubMedCrossRef Matsumoto Y, Fujii H, Aoyama H, et al. Surgical treatment of primary carcinoma of the gallbladder based on the histologic analysis of 48 surgical specimens. Am J Surg. 1992;163:239–45.PubMedCrossRef
19.
go back to reference Tsukada K, Hatakeyama K, Kurosaki I, et al. Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage. Surgery. 1996;120:816–22.PubMedCrossRef Tsukada K, Hatakeyama K, Kurosaki I, et al. Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage. Surgery. 1996;120:816–22.PubMedCrossRef
20.
go back to reference Bartlett DL, Fong Y, Fortner JG, et al. Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg. 1996;224:639–46.PubMedCentralPubMedCrossRef Bartlett DL, Fong Y, Fortner JG, et al. Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg. 1996;224:639–46.PubMedCentralPubMedCrossRef
21.
go back to reference Araida T, Higuchi R, Hamano M, et al. Should the extrahepatic bile duct be resected or preserved in R0 radical surgery for advanced gallbladder carcinoma? Results of a Japanese Society of Biliary Surgery Survey: a multicenter study. Surg Today. 2009;39:770–9.PubMedCrossRef Araida T, Higuchi R, Hamano M, et al. Should the extrahepatic bile duct be resected or preserved in R0 radical surgery for advanced gallbladder carcinoma? Results of a Japanese Society of Biliary Surgery Survey: a multicenter study. Surg Today. 2009;39:770–9.PubMedCrossRef
22.
go back to reference Wiggers JK, Groot Koerkamp B, Ovadia Z, et al. Patterns of recurrence after resection of gallbladder cancer without routine extrahepatic bile duct resection. HPB (Oxford). 2013. doi:10.1111/hpb.12188. Wiggers JK, Groot Koerkamp B, Ovadia Z, et al. Patterns of recurrence after resection of gallbladder cancer without routine extrahepatic bile duct resection. HPB (Oxford). 2013. doi:10.​1111/​hpb.​12188.
23.
go back to reference Choi SB, Han HJ, Kim WB, et al. Surgical strategy for T2 and T3 gallbladder cancer: is extrahepatic bile duct resection always necessary? Langenbecks Arch Surg. 2013;398:1137–44.PubMedCrossRef Choi SB, Han HJ, Kim WB, et al. Surgical strategy for T2 and T3 gallbladder cancer: is extrahepatic bile duct resection always necessary? Langenbecks Arch Surg. 2013;398:1137–44.PubMedCrossRef
24.
go back to reference Yagi H, Shimazu M, Kawachi S, et al. Retrospective analysis of outcome in 63 gallbladder carcinoma patients after radical resection. J Hepatobiliary Pancreat Surg. 2006;13:530–6.PubMedCrossRef Yagi H, Shimazu M, Kawachi S, et al. Retrospective analysis of outcome in 63 gallbladder carcinoma patients after radical resection. J Hepatobiliary Pancreat Surg. 2006;13:530–6.PubMedCrossRef
25.
go back to reference Endo I, Shimada H, Fujii Y, et al. Indications for curative resection of advanced gallbladder cancer with hepatoduodenal ligament invasion. J Hepatobiliary Pancreat Surg. 2001;8:505–10.PubMedCrossRef Endo I, Shimada H, Fujii Y, et al. Indications for curative resection of advanced gallbladder cancer with hepatoduodenal ligament invasion. J Hepatobiliary Pancreat Surg. 2001;8:505–10.PubMedCrossRef
26.
go back to reference Kaneoka Y, Yamaguchi A, Isogai M, et al. Hepatoduodenal ligament invasion by gallbladder carcinoma: histologic patterns and surgical recommendation. World J Surg. 2003;27:260–5.PubMedCrossRef Kaneoka Y, Yamaguchi A, Isogai M, et al. Hepatoduodenal ligament invasion by gallbladder carcinoma: histologic patterns and surgical recommendation. World J Surg. 2003;27:260–5.PubMedCrossRef
27.
go back to reference Chan KM, Yeh TS, Yu MC, et al. Gallbladder carcinoma with biliary invasion: clinical analysis of the differences from nonbiliary invasion. World J Surg. 2005;29:72–5.PubMedCrossRef Chan KM, Yeh TS, Yu MC, et al. Gallbladder carcinoma with biliary invasion: clinical analysis of the differences from nonbiliary invasion. World J Surg. 2005;29:72–5.PubMedCrossRef
28.
go back to reference Shukla PJ, Neve R, Barreto SG, et al. A new scoring system for gallbladder cancer (aiding treatment algorithm): an analysis of 335 patients. Ann Surg Oncol. 2008;15:3132–7.PubMedCrossRef Shukla PJ, Neve R, Barreto SG, et al. A new scoring system for gallbladder cancer (aiding treatment algorithm): an analysis of 335 patients. Ann Surg Oncol. 2008;15:3132–7.PubMedCrossRef
29.
go back to reference Kokudo N, Makuuchi M, Natori T, et al. Strategies for surgical treatment of gallbladder carcinoma based on information available before resection. Arch Surg. 2003;138:741–50.PubMedCrossRef Kokudo N, Makuuchi M, Natori T, et al. Strategies for surgical treatment of gallbladder carcinoma based on information available before resection. Arch Surg. 2003;138:741–50.PubMedCrossRef
30.
go back to reference Hawkins WG, DeMatteo RP, Jarnagin WR, et al. Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Ann Surg Oncol. 2004;11:310–5.PubMedCrossRef Hawkins WG, DeMatteo RP, Jarnagin WR, et al. Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Ann Surg Oncol. 2004;11:310–5.PubMedCrossRef
31.
go back to reference Nimura Y. Radical surgery: vascular and pancreatic resection for cholangiocarcinoma. HPB (Oxford). 2008;10:183–5.CrossRef Nimura Y. Radical surgery: vascular and pancreatic resection for cholangiocarcinoma. HPB (Oxford). 2008;10:183–5.CrossRef
32.
go back to reference Ebata T, Yokoyama Y, Igami T, et al. Hepatopancreatoduodenectomy for cholangiocarcinoma: a single center review of 85 consecutive patients. Ann Surg. 2012;256:297–305.PubMedCrossRef Ebata T, Yokoyama Y, Igami T, et al. Hepatopancreatoduodenectomy for cholangiocarcinoma: a single center review of 85 consecutive patients. Ann Surg. 2012;256:297–305.PubMedCrossRef
33.
go back to reference Sasaki R, Takahashi M, Funato O, et al. Hepatopancreatoduodenectomy with wide lymph node dissection for locally advanced carcinoma of the gallbladder: long term results. Hepatogastroenterology. 2002;49:912–5.PubMed Sasaki R, Takahashi M, Funato O, et al. Hepatopancreatoduodenectomy with wide lymph node dissection for locally advanced carcinoma of the gallbladder: long term results. Hepatogastroenterology. 2002;49:912–5.PubMed
34.
go back to reference Sakamoto Y, Nara S, Kishi Y, et al. Is extended hemihepatectomy plus pancreaticoduodenectomy justified for advanced bile duct cancer and gallbladder cancer? Surgery. 2013;153:794–800.PubMedCrossRef Sakamoto Y, Nara S, Kishi Y, et al. Is extended hemihepatectomy plus pancreaticoduodenectomy justified for advanced bile duct cancer and gallbladder cancer? Surgery. 2013;153:794–800.PubMedCrossRef
35.
go back to reference Lim CS, Jang JY, Lee SE, et al. Reappraisal of hepatopancreatoduodenectomy as a treatment modality for bile duct and gallbladder cancer. J Gastrointest Surg. 2012;16:1012–8.PubMedCrossRef Lim CS, Jang JY, Lee SE, et al. Reappraisal of hepatopancreatoduodenectomy as a treatment modality for bile duct and gallbladder cancer. J Gastrointest Surg. 2012;16:1012–8.PubMedCrossRef
36.
go back to reference Kaneoka Y, Yamaguchi A, Isogai M, et al. Hepatopancreatoduodenectomy: its suitability for bile duct cancer versus gallbladder cancer. J Hepatobiliary Pancreat Surg. 2007;14:142–8.PubMedCrossRef Kaneoka Y, Yamaguchi A, Isogai M, et al. Hepatopancreatoduodenectomy: its suitability for bile duct cancer versus gallbladder cancer. J Hepatobiliary Pancreat Surg. 2007;14:142–8.PubMedCrossRef
Metadata
Title
Extra-Hepatic Bile Duct Resection: an Insight in the Management of Gallbladder Cancer
Authors
Durgatosh Pandey
Pankaj Kumar Garg
N. M. L. Manjunath
Jyoti Sharma
Publication date
01-09-2015
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 3/2015
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-015-9737-9

Other articles of this Issue 3/2015

Journal of Gastrointestinal Cancer 3/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.